Furthermore, YTHDF2 is not essential for the cancer cells, which are less dependent upon upregulated MYC for longer survival of TNBC patients, (Einstein et al., 2021), suggesting it could be a potential therapeutic target for the drugs to overcome TNBC. This evidence concerns the gene YTHDF2 and cancer.